PBS updates

Risperdal (Risperidone)

risperidone 1 mg/mL oral liquid, 100 mL · ORAL · PBS code 11874Y

STREAMLINED

What it costs

AU$94.36 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2020-01-01.
  • • Repeats: 2.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Behavioural disturbances


Initial treatment


The condition must be characterised by psychotic symptoms and aggression; AND

Patient must have dementia of the Alzheimer type; AND

Patient must have failed to respond to non-pharmacological methods of treatment; AND

Patient must not receive more than 12 weeks of treatment under this restriction.

A patient may only qualify for 12 weeks of PBS-subsidised treatment under this restriction once in a 12 month period.

Sponsor: Janssen-Cilag Pty Ltd ABN 47 000 129 975

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.